"12" Result
Sort By:
Annotation
TPA for Stroke: The Story of a Controversial Drug explains the drug's beginnings within pharmaceutical giant Genentech, and its eventual marginalization due to a convergence of unfortunate political, fiscal, and medical circumstances.
Without warning stroke can paralyze, blind, or kill. Some victims recover, but many do not and may even suffer another disabling or fatal attack. The drug known as tPA can drastically reduce the long-term disability associated with stroke, but despite its near-miraculous capabil…
The blood-brain-barrier prevented harmful materials entering the brain and in the meantime is a barricade to therapeutic drug delivery. Intranasal drug delivery to circumvent blood-brain-barrier was developed in the past, to take advantages of a secret passage from the olfactory…
The author shares information based on his breakthrough research on nitric oxide in a program for cardiovascular health that recommends specific supplements, foods, and exercises designed to prevent strokes and heart disease.
The author shares information based on his breakthrough research on nitric oxide in a program for cardiovascular health that recommends specific supplements, foods, and exercises designed to prevent strokes and heart disease.
Tissue plasminogen activator (t-PA) is the only treatment currently proven to benefit stroke victims, but no physician guide to its safe and proper use exists. In Thrombolytic Therapy for Stroke, the world's leading experts detail the basic rationale, scientific evidence, and tr…
